Three different vaccines based on the 140-amino acid MUC1 peptide with seven tandemly repeated tumor-specific epitopes elicit distinct immune effector mechanisms in wild-type versus MUC1-transgenic mice with different potential for tumor rejection
(Q73896217)
scientific article published on 01 June 2001
scientific article published on 01 June 2001
Language:
other details
| description | scientific article published on 01 June 2001 |
External Links
| (P356) |
10.4049/JIMMUNOL.166.11.6555
|
| (P698) |
11359807
|